Regeneron Pharma (REGN) PT Lowered to $410 at Bernstein
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $833.48 +1.17%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 30
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 30
Join SI Premium – FREE
Bernstein lowered its price target on Regeneron Pharma (NASDAQ: REGN) to $410.00 (from $420.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- GitLab Inc (GTLB) PT Raised to $55 at DA Davidson, Neutral Rating Maintained
- GitLab Inc (GTLB) PT Raised to $52 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
